-
A new free resource, Patient Experience Improvement Toolkit: A Guide for Family Planning, is available to help family planning agencies develop patient experience goals; measure and use patient experience data; enhance interpersonal skills; and improve clinic sites, online and offline.
-
The female diaphragm offers hormone-free contraception that is female-initiated and female-controlled. Currently available diaphragms require a pelvic examination and fitting to ensure proper size and placement of the device.
-
The Internet and the cell phone are helping patients in not only seeking testing for sexually transmitted infections (STIs), but learning their test results and promoting treatment for themselves and their partners.
-
For the last 15 years, emerging evidence has encouraged clinicians who prescribe hormonal contraception to quick start patients on their chosen contraceptive method on the day of the visit, instead of waiting until after menses begins.
-
About 1.7 million women of childbearing age are prescribed Food and Drug Administration Category D or Category X medications each year. However, despite label warnings, about 6% of U.S. pregnancies occur in women taking medications with known teratogenic risk.
-
A new report emphasizes the need to energize efforts to reach the potential of human papillomavirus (HPV) vaccines to save lives and prevent millions of avoidable cancers and HPV-related conditions in men and women.
-
Bayer HealthCare Pharmaceuticals has received Food and Drug Administration approval for a new inserter for its Mirena intrauterine contraceptive.
-
New chlamydia prevalence estimates confirm that young women particularly young African American women continue to bear a disproportionate burden of disease in the United States.
-
Results from the 2013 National Youth Risk Behavior Survey indicate that among high school students who are sexually active, condom use has declined from 63% in 2003 to 59% in 2013. This decline follows a period of increased condom use throughout the 1990s and early 2000s.
-
Its estimated that 859 out of 100,000 women of reproductive age receive a cancer diagnosis each year in the United States. Up to 80% of all women diagnosed with cancer prior to age 50 survive at least five years.
